EUROPEAN JOURNAL OF HAEMATOLOGY, vol.95, no.3, pp.244-253, 2015 (SCI-Expanded)
ObjectivesThe randomized comparison of deferasirox to deferoxamine for myocardial iron removal in patients with transfusion-dependent anemias (CORDELIA) gave the opportunity to assess relative prevalence and body distribution of iron overload in screened patients.